Evidence map›Paper›PMID 40407905›Full record

ArticleActa neuropathologica2025

Sequence and trajectory of early Alzheimer's disease-related tau inclusions in the hippocampal formation of cases without amyloid-β deposits.

Heiko Braak, Benjamin Mayer, Simone Feldengut, Michael Schön, Kelly Del Tredici

Abstract read
In one paragraph

Article in Acta neuropathologica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Primary age-related tauopathy.Acta neuropathologica · 2025
    Review
  14. Celebrating neuropathology's contributions to Alzheimer's Disease Research Centers.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  15. Review
  16. Article
  17. Article
  18. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Heiko BraakDepartment of Neurology, Center for Biomedical Research, Clinical Neuroanatomy, University of Ulm, Helmholtzstrasse 8/1, 89081, Ulm, Germany. heiko.braak@uni-ulm.de.ORCID http://orcid.org/0000-0002-6776-1045
Benjamin MayerInstitute of Epidemiology and Medical Biometry, University of Ulm, 89075, Ulm, Germany.ORCID http://orcid.org/0000-0003-1042-9006
Simone FeldengutDepartment of Neurology, Center for Biomedical Research, Clinical Neuroanatomy, University of Ulm, Helmholtzstrasse 8/1, 89081, Ulm, Germany.ORCID http://orcid.org/0009-0003-0470-0063
Michael Schön *Institute for Anatomy and Cell Biology, University of Ulm, 89081, Ulm, Germany.ORCID https://orcid.org/0000-0002-8905-1810
Kelly Del Tredici *Department of Neurology, Center for Biomedical Research, Clinical Neuroanatomy, University of Ulm, Helmholtzstrasse 8/1, 89081, Ulm, Germany.ORCID https://orcid.org/0000-0002-9130-7838

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sporadic Alzheimer's disease (AD) involves specific neuronal types and progresses in a systematic manner, permitting subdivision into six neuropathological stages. Neurofibrillary tangle (NFT) stages I-III display abnormal tau inclusions confined to subcortical nuclei and temporal allocortical regions, frequently without amyloid β (Aβ) deposition. We previously suggested a sequence of neuronal involvement in AD that could proceed from entorhinal pre-α cells to hippocampal prosubicular pyramidal cells and the CA1/CA2 sectors, from there to the thorny excrescences on mossy cells in CA3/CA4, and, finally, from the mossy cells to dentate fascia (Fd) granular cells. Here, we aimed to see if associations existed between the early NFT stages I-III, when Aβ deposits are frequently absent, and the following four categories: (1) anatomical regions and abnormal morphological tau changes in region-specific layers, (2) nerve cell loss, (3) APOE genotype, and (4) the trajectory (directionality) of tau progression in the hippocampal formation. To do so, we examined the transentorhinal/entorhinal regions and hippocampal formation using AT8-immunohistochemistry in 100 µm sections from N = 308 brains with tau inclusions lacking Aβ deposits between NFT stages I and III (average age at death 66.7 years for females, 66.4 years for males). Our results indicated a significantly (p < 0.001) ordered progression of abnormal tau in a direction opposite to currently known unidirectional intrahippocampal connections, thereby indirectly supporting the idea of transneuronal abnormal tau spreading, i.e., anterogradely, through the hippocampal formation. Tau-related neuronal loss was also significant (p < 0.001 for the transentorhinal/entorhinal regions and for sectors CA1/CA2 and p = 0.003 for CA3/CA4/Fd). These findings challenge the amyloid cascade and the PART hypotheses, corroborating the concept that early AD-related tau inclusions and tau-related neuronal loss occur independently of Aβ deposition.

Indexed as

Alzheimer DiseaseHippocampusInclusion Bodiestau ProteinsAgedAged, 80 and overAmyloid beta-PeptidesDisease ProgressionFemaleHumansMaleMiddle AgedNeurofibrillary TanglesNeuronsAmyloid beta-PeptidesMAPT protein, humantau ProteinsAlzheimer’s diseaseAT8Cornu ammonisDendritic tauEntorhinal regionFascia dentataGhost threadsHippocampal formationNeurofibrillary tangles/neuropil threadsNeuronal lossNeuron-to-neuron transmissionPerinuclear rimsPretangleThorny excrescences

Identifiers

PMID40407905
PMCPMC12102137

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.